Liu Shu Clinical Trial Pipeline: 3 Active Trials, 2 Changes This Month

3

Active Trials

2

Recruiting

1

Disease Areas

2

Changes, 30 Days

What Changed in the Last 30 Days

Detected	Trial	Change
2026-08-05	NCT07739511 Paclitaxel Oral Solution in HER2-Positive Breast Cancer Neoadjuvant Therapy: A…	Recruitment opened
2026-08-05	NCT07739485 Paclitaxel Oral Solution in Triple Neagtive Breast Cancer Neoadjuvant Therapy: A…	Recruitment opened

New Trial Filings, Last 30 Days

First Posted	Trial	Phase	Status
2026-07-31	NCT07739485 Paclitaxel Oral Solution in Triple Neagtive Breast Cancer Neoadjuvant Therapy: A…	Phase 1/2	Recruiting
2026-07-31	NCT07739511 Paclitaxel Oral Solution in HER2-Positive Breast Cancer Neoadjuvant Therapy: A…	Phase 1/2	Recruiting

Active Trials by Phase

Phase 1/2

2

Not specified

1

Active Trials

NCT ID	Title	Condition	Status
Phase 1/2
NCT07739485	Paclitaxel Oral Solution in Triple Neagtive Breast Cancer Neoadjuvant Therapy: A…	Triple -Negative Breast Cancer	Recruiting
NCT07739511	Paclitaxel Oral Solution in HER2-Positive Breast Cancer Neoadjuvant Therapy: A…	HER2 + Breast Cancer	Recruiting
Not specified
NCT06605690	An Exploratory Clinical Study of Dalpiciclib an'd Letrozole Combined With Anlotinib…	Breast Cancer	Not Yet Recruiting

Disease Areas

Get alerts when Liu Shu's trials change

Status changes, date slips, and new filings — detected daily, delivered to your inbox.